SCHEMBL6498794

SCHEMBL6498794

COC(=O)C(C)NC(=O)C1CCN(C(=O)/C=C/c2ccc(N(C)C)c(Cl)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 4/20 0.49
NPC1 O15118 9/20 0.45
RAB9A P51151 9/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
CCR2 P41597 4/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
APOBEC3A P31941 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
BCHE P06276 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6498797 1.00 CAPN1 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6495203 0.91 CAPN1 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL8296935 0.91 CAPN1 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6495207 0.91 CAPN1 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6503200 0.87 ITGB2 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6498757 0.87 CAPN1 (0.47) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6503201 0.87 ITGB2 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6498751 0.87 CAPN1 (0.47) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL13879638 0.85 NPC1 (0.62) NPC1RAB9AALDH1A1SMN1; SMN2CCR2
SCHEMBL6498627 0.79 ITGB2 (0.51) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed